4
Changes in Ownership
Grace Therapeutics, Inc. Filed Acc 0001140361-26-036125
Chief Executive Officer bought 100,000 shares at $2.14 ($214,000)
From the SEC's structured data for this filing
Trades in this filing
Kohli Prashant · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-09 | Purchase : show line 1 in the form | +100,000 | $2.14 | $214,000 | 121,357 | D |
| Open-market purchases · 100,000 sh · avg $2.14 · $214,000 | ||||||
Loading xslF345X06/form4.xml…